SCHEMBL7959137

SCHEMBL7959137

Cn1nc(CCCN2CCN(c3ccccc3)CC2)c2c1CCCC2

nearest known ligand 0.53

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
SIGMAR1 Q99720 6/20 0.53
KCNH2 Q12809 2/20 0.51
CYP2D6 P10635 1/20 0.48
DRD2 P14416 5/20 0.47
HTR2A P28223 2/20 0.46
HTR2C P28335 1/20 0.46
HTR2B P41595 1/20 0.46
HTR1A P08908 3/20 0.46
DRD3 P35462 2/20 0.46
DRD4 P21917 1/20 0.46
HRH1 P35367 1/20 0.45
TMEM97 Q5BJF2 1/20 0.45
ADRA1D P25100 1/20 0.45
ADRA1A P35348 1/20 0.45
ADRA1B P35368 1/20 0.45
HTR7 P34969 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7957403 0.89 MAPT (0.46) SIGMAR1KCNH2DRD2HTR2AHTR2C
SCHEMBL7959986 0.88 HTR1A (0.51) SIGMAR1DRD2HTR2AHTR2CHTR2B
SCHEMBL7959536 0.88 SIGMAR1 (0.52) SIGMAR1DRD2HTR2AHTR2CHTR1A
SCHEMBL7963930 0.88 SIGMAR1 (0.53) SIGMAR1KCNH2CYP2D6DRD2HTR2A
SCHEMBL7963943 0.84 MAPT (0.50) SIGMAR1KCNH2HTR1AHTR7
SCHEMBL7959679 0.82 DRD3 (0.49) SIGMAR1KCNH2DRD2HTR2AHTR2C
SCHEMBL5775204 0.80 SIGMAR1 (0.52) SIGMAR1KCNH2CYP2D6DRD2HTR2A
SCHEMBL7949208 0.78 SIGMAR1 (0.53) SIGMAR1KCNH2CYP2D6DRD2HTR2A
Fumaric Acid SCHEMBL7959573 0.76 SIGMAR1 (0.49) SIGMAR1DRD2HTR2AHTR2CHTR1A
Maleic Acid SCHEMBL7959572 0.76 SIGMAR1 (0.49) SIGMAR1DRD2HTR2AHTR2CHTR1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0885883-A1 FUSED HETEROCYCLIC COMPOUNDS AND PHARMACEUTICAL APPLICATIONS THEREOF YOSHITOMI PHARMACEUTICAL INDUSTRIES, LTD. (JP) 1998-12-23 EP claimed
US-6187774-B1 N-PIPERAZINYLALKYLINDAZOLE DERIVATIVES; PSYCHOLOGICAL DISORDERS, SCHIZOPHRENIA; SIDE EFFECT REDUCTION YOSHITOMI PHARMACEUTICAL INDUSTRIES, LTD. (JP) 2001-02-13 US disclosed
EP-0885883-A1 FUSED HETEROCYCLIC COMPOUNDS AND PHARMACEUTICAL APPLICATIONS THEREOF YOSHITOMI PHARMACEUTICAL INDUSTRIES, LTD. (JP) 1998-12-23 EP disclosed